Editas Medicine
EDIT
$5.47
Share price
4.99%
Change (1 day)
-34.10%
Change (1 year)
Editas Medicine (EDIT) - Total debt
Total debt on the balance sheet as of December 2023 : $36.53 M
According to Editas Medicine 's latest financial reports the company's total debt is $36.53 M. A company’s total debt is the sum of all current and non-current debts.
Editas Medicine - Total debt on balance sheet (from 2014 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023-12-31 | $36.53 M | -16.86% |
| 2022-12-31 | $43.94 M | 66.6% |
| 2021-12-31 | $26.37 M | 0.93% |
| 2020-12-31 | $26.13 M | -10.13% |
| 2019-12-31 | $29.08 M | -10.29% |
| 2018-12-31 | $32.41 M | -20.8% |
| 2017-12-31 | $40.93 M | -9.24% |
| 2016-12-31 | $45.09 M | -77.44% |
| 2015-12-31 | $0.19 B | 48541.12% |
| 2014-12-31 | $0.41 M | -80.53% |
| 2013-12-31 | $2.11 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $1.5 M | -95.89% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $47.82 M | 30.88% | 🇬🇧 UK |
 Novavax NVAX | $0.22 B | 527.00% | 🇺🇸 USA |
 Novocure
NVCR | $0.59 B | 1,531.93% | Jersey |